Copyright Reports & Markets. All rights reserved.

Global Plasma Therapy Market Size, Status and Forecast 2019-2025

Request for Sample of this report
Buy now

Table of Contents

    1 Report Overview

    • 1.1 Study Scope
    • 1.2 Key Market Segments
    • 1.3 Players Covered
    • 1.4 Market Analysis by Type
      • 1.4.1 Global Plasma Therapy Market Size Growth Rate by Type (2014-2025)
      • 1.4.2 Pure PRP
      • 1.4.3 Leucocyte-rich PRP
      • 1.4.4 Pure Platelet-rich Fibrin (PRF)
      • 1.4.5 Leukocyte-rich Fibrin (L-PRF)
    • 1.5 Market by Application
      • 1.5.1 Global Plasma Therapy Market Share by Application (2014-2025)
      • 1.5.2 Orthopedics
      • 1.5.3 Dermatology
      • 1.5.4 Dental
      • 1.5.5 Cardiac Muscle Injury
      • 1.5.6 Nerve Injury
      • 1.5.7 Others
    • 1.6 Study Objectives
    • 1.7 Years Considered

    2 Global Growth Trends

    • 2.1 Plasma Therapy Market Size
    • 2.2 Plasma Therapy Growth Trends by Regions
      • 2.2.1 Plasma Therapy Market Size by Regions (2014-2025)
      • 2.2.2 Plasma Therapy Market Share by Regions (2014-2019)
    • 2.3 Industry Trends
      • 2.3.1 Market Top Trends
      • 2.3.2 Market Drivers
      • 2.3.3 Market Opportunities

    3 Market Share by Key Players

    • 3.1 Plasma Therapy Market Size by Manufacturers
      • 3.1.1 Global Plasma Therapy Revenue by Manufacturers (2014-2019)
      • 3.1.2 Global Plasma Therapy Revenue Market Share by Manufacturers (2014-2019)
      • 3.1.3 Global Plasma Therapy Market Concentration Ratio (CR5 and HHI)
    • 3.2 Plasma Therapy Key Players Head office and Area Served
    • 3.3 Key Players Plasma Therapy Product/Solution/Service
    • 3.4 Date of Enter into Plasma Therapy Market
    • 3.5 Mergers & Acquisitions, Expansion Plans

    4 Breakdown Data by Type and Application

    • 4.1 Global Plasma Therapy Market Size by Type (2014-2019)
    • 4.2 Global Plasma Therapy Market Size by Application (2014-2019)

    5 United States

    • 5.1 United States Plasma Therapy Market Size (2014-2019)
    • 5.2 Plasma Therapy Key Players in United States
    • 5.3 United States Plasma Therapy Market Size by Type
    • 5.4 United States Plasma Therapy Market Size by Application

    6 Europe

    • 6.1 Europe Plasma Therapy Market Size (2014-2019)
    • 6.2 Plasma Therapy Key Players in Europe
    • 6.3 Europe Plasma Therapy Market Size by Type
    • 6.4 Europe Plasma Therapy Market Size by Application

    7 China

    • 7.1 China Plasma Therapy Market Size (2014-2019)
    • 7.2 Plasma Therapy Key Players in China
    • 7.3 China Plasma Therapy Market Size by Type
    • 7.4 China Plasma Therapy Market Size by Application

    8 Japan

    • 8.1 Japan Plasma Therapy Market Size (2014-2019)
    • 8.2 Plasma Therapy Key Players in Japan
    • 8.3 Japan Plasma Therapy Market Size by Type
    • 8.4 Japan Plasma Therapy Market Size by Application

    9 Southeast Asia

    • 9.1 Southeast Asia Plasma Therapy Market Size (2014-2019)
    • 9.2 Plasma Therapy Key Players in Southeast Asia
    • 9.3 Southeast Asia Plasma Therapy Market Size by Type
    • 9.4 Southeast Asia Plasma Therapy Market Size by Application

    10 India

    • 10.1 India Plasma Therapy Market Size (2014-2019)
    • 10.2 Plasma Therapy Key Players in India
    • 10.3 India Plasma Therapy Market Size by Type
    • 10.4 India Plasma Therapy Market Size by Application

    11 Central & South America

    • 11.1 Central & South America Plasma Therapy Market Size (2014-2019)
    • 11.2 Plasma Therapy Key Players in Central & South America
    • 11.3 Central & South America Plasma Therapy Market Size by Type
    • 11.4 Central & South America Plasma Therapy Market Size by Application

    12 International Players Profiles

    • 12.1 BiolifePlasmaServices
      • 12.1.1 BiolifePlasmaServices Company Details
      • 12.1.2 Company Description and Business Overview
      • 12.1.3 Plasma Therapy Introduction
      • 12.1.4 BiolifePlasmaServices Revenue in Plasma Therapy Business (2014-2019)
      • 12.1.5 BiolifePlasmaServices Recent Development
    • 12.2 CambrynBiologicsLLC
      • 12.2.1 CambrynBiologicsLLC Company Details
      • 12.2.2 Company Description and Business Overview
      • 12.2.3 Plasma Therapy Introduction
      • 12.2.4 CambrynBiologicsLLC Revenue in Plasma Therapy Business (2014-2019)
      • 12.2.5 CambrynBiologicsLLC Recent Development
    • 12.3 Biotest
      • 12.3.1 Biotest Company Details
      • 12.3.2 Company Description and Business Overview
      • 12.3.3 Plasma Therapy Introduction
      • 12.3.4 Biotest Revenue in Plasma Therapy Business (2014-2019)
      • 12.3.5 Biotest Recent Development
    • 12.4 CSLLtd.
      • 12.4.1 CSLLtd. Company Details
      • 12.4.2 Company Description and Business Overview
      • 12.4.3 Plasma Therapy Introduction
      • 12.4.4 CSLLtd. Revenue in Plasma Therapy Business (2014-2019)
      • 12.4.5 CSLLtd. Recent Development
    • 12.5 GrifolsInternationalS.A.
      • 12.5.1 GrifolsInternationalS.A. Company Details
      • 12.5.2 Company Description and Business Overview
      • 12.5.3 Plasma Therapy Introduction
      • 12.5.4 GrifolsInternationalS.A. Revenue in Plasma Therapy Business (2014-2019)
      • 12.5.5 GrifolsInternationalS.A. Recent Development
    • 12.6 KedrionS.P.A.
      • 12.6.1 KedrionS.P.A. Company Details
      • 12.6.2 Company Description and Business Overview
      • 12.6.3 Plasma Therapy Introduction
      • 12.6.4 KedrionS.P.A. Revenue in Plasma Therapy Business (2014-2019)
      • 12.6.5 KedrionS.P.A. Recent Development
    • 12.7 LFBSA
      • 12.7.1 LFBSA Company Details
      • 12.7.2 Company Description and Business Overview
      • 12.7.3 Plasma Therapy Introduction
      • 12.7.4 LFBSA Revenue in Plasma Therapy Business (2014-2019)
      • 12.7.5 LFBSA Recent Development
    • 12.8 BioProductLaboratoryLtd.(BPL)
      • 12.8.1 BioProductLaboratoryLtd.(BPL) Company Details
      • 12.8.2 Company Description and Business Overview
      • 12.8.3 Plasma Therapy Introduction
      • 12.8.4 BioProductLaboratoryLtd.(BPL) Revenue in Plasma Therapy Business (2014-2019)
      • 12.8.5 BioProductLaboratoryLtd.(BPL) Recent Development
    • 12.9 ChinaBiologicProducts,Inc.
      • 12.9.1 ChinaBiologicProducts,Inc. Company Details
      • 12.9.2 Company Description and Business Overview
      • 12.9.3 Plasma Therapy Introduction
      • 12.9.4 ChinaBiologicProducts,Inc. Revenue in Plasma Therapy Business (2014-2019)
      • 12.9.5 ChinaBiologicProducts,Inc. Recent Development
    • 12.10 Octapharma
      • 12.10.1 Octapharma Company Details
      • 12.10.2 Company Description and Business Overview
      • 12.10.3 Plasma Therapy Introduction
      • 12.10.4 Octapharma Revenue in Plasma Therapy Business (2014-2019)
      • 12.10.5 Octapharma Recent Development

    13 Market Forecast 2019-2025

    • 13.1 Market Size Forecast by Regions
    • 13.2 United States
    • 13.3 Europe
    • 13.4 China
    • 13.5 Japan
    • 13.6 Southeast Asia
    • 13.7 India
    • 13.8 Central & South America
    • 13.9 Market Size Forecast by Product (2019-2025)
    • 13.10 Market Size Forecast by Application (2019-2025)

    14 Analyst's Viewpoints/Conclusions

      15 Appendix

      • 15.1 Research Methodology
        • 15.1.1 Methodology/Research Approach
          • 15.1.1.1 Research Programs/Design
          • 15.1.1.2 Market Size Estimation
          • 12.1.1.3 Market Breakdown and Data Triangulation
        • 15.1.2 Data Source
          • 15.1.2.1 Secondary Sources
          • 15.1.2.2 Primary Sources
      • 15.2 Disclaimer

      In 2018, the global Plasma Therapy market size was million US$ and it is expected to reach million US$ by the end of 2025, with a CAGR of during 2019-2025.

      This report focuses on the global Plasma Therapy status, future forecast, growth opportunity, key market and key players. The study objectives are to present the Plasma Therapy development in United States, Europe and China.

      The key players covered in this study
      BiolifePlasmaServices
      CambrynBiologicsLLC
      Biotest
      CSLLtd.
      GrifolsInternationalS.A.
      KedrionS.P.A.
      LFBSA
      BioProductLaboratoryLtd.(BPL)
      ChinaBiologicProducts,Inc.
      Octapharma

      Market segment by Type, the product can be split into
      Pure PRP
      Leucocyte-rich PRP
      Pure Platelet-rich Fibrin (PRF)
      Leukocyte-rich Fibrin (L-PRF)

      Market segment by Application, split into
      Orthopedics
      Dermatology
      Dental
      Cardiac Muscle Injury
      Nerve Injury
      Others

      Market segment by Regions/Countries, this report covers
      United States
      Europe
      China
      Japan
      Southeast Asia
      India
      Central & South America

      The study objectives of this report are:
      To analyze global Plasma Therapy status, future forecast, growth opportunity, key market and key players.
      To present the Plasma Therapy development in United States, Europe and China.
      To strategically profile the key players and comprehensively analyze their development plan and strategies.
      To define, describe and forecast the market by product type, market and key regions.

      In this study, the years considered to estimate the market size of Plasma Therapy are as follows:
      History Year: 2014-2018
      Base Year: 2018
      Estimated Year: 2019
      Forecast Year 2019 to 2025
      For the data information by region, company, type and application, 2018 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.

      Buy now